• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    ICL Reports Second Quarter 2024 Results

    8/14/24 2:12:00 AM ET
    $ICL
    Agricultural Chemicals
    Industrials
    Get the next $ICL alert in real time by email

    Continued to deliver sequential growth, with sales of $1.8 billion, operating income of $211 million and adjusted EBITDA of $377 million

    Raising guidance for specialties-driven businesses

    ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2024. Consolidated sales were $1.75 billion versus $1.87 billion in the prior year. Operating income was $211 million, with adjusted operating income of $225 million, versus $300 million of operating income in the second quarter of last year. Adjusted EBITDA was $377 million versus $441 million. Diluted earnings per share were $0.09, with adjusted diluted EPS of $0.10, versus $0.13 in the second quarter of last year.

    "ICL delivered sequentially improving EBITDA for the third consecutive quarter, as we continued to build momentum by focusing on the areas under our control, including the introduction of innovative solutions and continued cost efficiencies, while managing the risks associated with geopolitical uncertainties. All three of our specialties-driven segments were up versus the second quarter of 2023 and contributed to the sequential increase in adjusted EBITDA and margins," said Raviv Zoller, president and CEO of ICL. "While we were ahead of our expectations in the first half of the year, we remain cautious regarding short-term expectations for some of the end markets we serve, including electronics, housing and construction, and food."

    The company raised its guidance for full year 2024 and now expects specialties-driven EBITDA of between $0.8 billion to $1.0 billion, an increase from previous guidance of $0.7 billion to $0.9 billion, without any change to expected potash sales volumes. (1a)

    Key Financials

    Second Quarter 2024

    US$M

    Ex. per share data

    2Q'24

    1Q'24

    2Q'23

    Sales

    $1,752

    $1,735

    $1,868

    Gross profit

    $568

    $557

    $679

    Gross margin

    32%

    32%

    36%

    Operating income

    $211

    $203

    $300

    Adjusted operating income (1)

    $225

    $215

    $300

    Operating margin

    12%

    12%

    16%

    Adjusted operating margin (1)

    13%

    12%

    16%

    Net income attributable to shareholders

    $115

    $109

    $163

    Adjusted net income attributable to shareholders (1)

    $126

    $118

    $163

    Adjusted EBITDA (1)(2)

    $377

    $362

    $441

    Adjusted EBITDA margin (1)(2)

    22%

    21%

    24%

    Diluted earnings per share

    $0.09

    $0.08

    $0.13

    Diluted adjusted earnings per share (1)

    $0.10

    $0.09

    $0.13

    Cash flows from operating activities (3)

    $316

    $279

    $433

    (1)

    Adjusted operating income and margin, adjusted net income attributable to shareholders, adjusted EBITDA and margin, and diluted adjusted earnings per share are non-GAAP financial measures. Please refer to the adjustments table and disclaimer.

    (2)

    In the first half of 2024, the company's adjusted EBITDA was positively impacted by an immaterial accounting reclassification. Please refer to the 6-K filing for additional details.

    (3)

    Reclassified - see Note 2 to the company's interim financial statements.

    Industrial Products

    Second quarter 2024

    • Sales of $315 million vs. $300 million.
    • EBITDA of $74 million vs. $74 million.
    • Third quarter of sequential improvement in EBITDA, with continued focus on cost savings and expanding customer relationships.

    Key developments

    • Flame retardants: Sales increased year-over-year, as higher volumes for brominated solutions were partially offset by lower prices overall, as demand from both the electronics and construction end-markets remained soft.
    • Elemental bromine: Sales increased year-over-year, as higher volumes offset lower prices.
    • Oil and gas: Clear brine fluid sales declined versus the prior year, due to inclement weather and a shift in oil rig schedules.
    • Specialty minerals: Lower prices drove a year-over-year decrease in sales, despite higher volumes.

    Potash

    Second quarter 2024

    • Sales of $422 million vs. $582 million.
    • EBITDA of $118 million vs. $213 million.
    • Grain Price Index decreased 15.2% year-over-year, with rice up 3.2%, while corn, soybeans and wheat were down 30.1%, 18.0% and 24.7%, respectively. On a sequential basis, the Grain Price Index increased 2.7%, with corn, wheat and rice up 4.5%, 5.3% and 1.7%, respectively, while soy declined 0.5%.

    Key developments

    • Potash price: $300 per ton (CIF).

    - Down 7% sequentially and 26% year-over-year.

    • Potash sales volumes: 1,153 thousand metric tons.

    - Decreased by 108 thousand metric tons year-over-year.

    • ICL Dead Sea

    - Stable cost per ton, despite lower production year-over-year

    • ICL Iberia

    - Continued operational improvement, with record second quarter production.

    • Metal Magnesium

    - Lower prices offset higher volumes, as market prices trended lower versus the prior year.

    Phosphate Solutions

    Second quarter 2024

    • Sales of $572 million vs. $565 million.
    • EBITDA of $146 million vs. $129 million.
    • Second quarter of sequential improvement in sales, with EBITDA up 11% sequentially and 13% year-over-year. Pricing remained firm in the second quarter, however, changing supply dynamics are expected to influence future quarters.

    Key developments

    • White phosphoric acid: Sales declined year-over-year, as increased volumes – especially in Europe and Asia – were unable to offset lower prices globally.
    • Industrial phosphates: Sales decreased, as improved volumes were offset by weaker pricing.
    • Food phosphates: Sales decreased, as higher volumes were offset by lower market prices, which reflected reduced raw material input costs.
    • Battery materials: Increased volumes in China, with U.S. customer innovation and qualification center (CIQC) expected to be completed by year-end.
    • Commodity phosphates: Sequential sales improvement reflected an increase in volumes, which offset a decrease in prices.
    • Competition remains elevated across all global markets, as increased availability pressured prices.

    Growing Solutions

    Second quarter 2024

    • Sales of $494 million vs. $481 million.
    • EBITDA of $45 million vs. $22 million.
    • Year-over-year improvement in sales and EBITDA of 3% and more than 100%, respectively, with second quarter of sequential improvement in both sales and EBITDA.

    Key developments

    • Brazil: Sales declined, but a better mix of higher margin foliar sales drove improved profitability.
    • Europe: Sales increased, with improved gross profit, as higher quantities and lower raw material costs offset lower prices.
    • North America: Sales improved year-over-year on higher volumes.
    • Asia: Sales in China increased, driven by volumes, and as additional production was brought online.
    • Product trends: Specialty agriculture sales increased versus the prior year, as stronger volumes offset lower prices. Turf and ornamental markets returned to more stable pre-covid demand levels, with higher sales, volumes and gross profit year-over-year. The polysulphate market continued to be challenging, as lower prices impacted profitability.

    Financial Items

    Financing Expenses

    Net financing expenses for the second quarter of 2024 were $33 million, down versus $49 million in the corresponding quarter of last year.

    Tax Expenses

    Reported tax expenses in the second quarter of 2024 were $48 million, reflecting an effective tax rate of 27%, compared to $84 million in the corresponding quarter of last year, reflecting an effective tax rate of 33%. The lower tax rate reflected a lower surplus profit, mainly due to a decrease in potash prices.

    Available Liquidity

    ICL's available cash resources, which are comprised of cash and deposits, unutilized revolving credit facility, and unutilized securitization, totaled $1,652 million, as of June 30, 2024.

    Outstanding Net Debt

    As of June 30, 2024, ICL's net financial liabilities amounted to $2,031 million, a decrease of $64 million compared to December 31, 2023.

    Dividend Distribution

    In connection with ICL's second quarter 2024 results, the Board of Directors declared a dividend of 4.884 cents per share, or approximately $63 million, versus 6.321 cents per share, or approximately $81 million, in the second quarter of last year. The dividend will be payable on September 18, 2024, to shareholders of record as of September 4, 2024.

    About ICL

    ICL Group Ltd. is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 12,000 people worldwide, and its 2023 revenue totaled approximately $7.5 billion.

    For more information, visit ICL's website at icl-group.com.

    To access ICL's interactive CSR report, visit icl-group-sustainability.com.

    You can also learn more about ICL on Facebook, LinkedIn, YouTube, X and Instagram.

    Guidance

    (1a) The company only provides guidance on a non-GAAP basis. The company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material, and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. The company undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The company provides guidance for specialties-driven EBITDA, which includes Industrial Products, Growing Solutions and Phosphate Solutions, as the Phosphate Solutions business is now predominantly specialties focused. For the Potash business, the company is providing sales volume guidance. The company believes this information provides greater transparency, as these new metrics are less impacted by fertilizer commodity prices, given the extreme volatility in recent years.

    Non-GAAP Statement

    The company discloses in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Management uses adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. The company calculates adjusted operating income by adjusting operating income to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below. Certain of these items may recur. The company calculates adjusted net income attributable to the company's shareholders by adjusting net income attributable to the company's shareholders to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below, excluding the total tax impact of such adjustments. The company calculates diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under "Consolidated adjusted EBITDA, and diluted adjusted earnings per share for the periods of activity" below, which were adjusted for in calculating the adjusted operating income.

    You should not view adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the company's shareholders determined in accordance with IFRS, and you should note that the company's definitions of adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of the company's non-IFRS financial measures as tools for comparison. However, the company believes adjusted operating income, adjusted net income attributable to the company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management, and investors by excluding certain items that management believes are not indicative of ongoing operations. Management uses these non-IFRS measures to evaluate the company's business strategies and management performance. The company believes these non‑IFRS measures provide useful information to investors because they improve the comparability of financial results between periods and provide for greater transparency of key measures used to evaluate performance.

    The company presents a discussion in the period-to-period comparisons of the primary drivers of change in the company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends on the company's businesses. The company has based the following discussion on its financial statements. You should read such discussion together with the company's financial statements.

    Forward Looking Statements

    This announcement contains statements that constitute "forward‑looking statements," many of which can be identified by the use of forward‑looking words such as "anticipate," "believe," "could," "expect," "should," "plan," "intend," "estimate," "strive," "forecast," "targets" and "potential," among others. The company is relying on the safe harbor provided in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in making such forward-looking statements.

    Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding intent, belief or current expectations. Forward‑looking statements are based on management's beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties and actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to:

    Loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; litigation, arbitration and regulatory proceedings; disruptions at seaport shipping facilities or regulatory restrictions affecting the ability to export products overseas; changes in exchange rates or prices compared to those the company is currently experiencing; general market, political or economic conditions in the countries in which the company operates; price increases or shortages with respect to principal raw materials; pandemics may create disruptions, impacting sales, operations, supply chain and customers; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at the plants; labor disputes, slowdowns and strikes involving employees; pension and health insurance liabilities; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; information technology systems or breaches of the company, or its service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from the company's cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of the businesses; the company is exposed to risks relating to its current and future activity in emerging markets; changes in demand for its fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond the company's control; disruption of the company, or its service providers', sales of magnesium products being affected by various factors that are not within the company's control; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of the company's workers and processes; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; war or acts of terror and/or political, economic and military instability in Israel and its region, including the current state of war declared in Israel and any resulting disruptions to supply and production chains; filing of class actions and derivative actions against the company, its executives and Board members; closing of transactions, mergers and acquisitions; and other risk factors discussed under "Item 3 - Key Information— D. Risk Factors" in the company's Annual Report on Form 20-F for the year ended December 31, 2023, filed with the U.S. Securities and Exchange Commission (SEC) on March 14, 2024 (the Annual Report).

    Forward‑looking statements speak only as of the date they are made, and, except as otherwise required by law, the company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements, targets or goals in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events. Investors are cautioned to consider these risk and uncertainties and to not place undue reliance on such information. Forward-looking statements should not be read as a guarantee of future performance or results and are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements.

    This report for the second quarter of 2024 should be read in conjunction with the Annual Report of 2023 published by the company on Form 20-F and the report for the first quarter of 2024 published by the company, including the description of events occurring subsequent to the date of the statement of financial position, as filed with the U.S. SEC.

    Appendix

    Condensed Consolidated Statements of Income (Unaudited)

    $ millions

    Three-months ended

    Six-months ended

    Year ended

     

    June 30,

    2024

    June 30,

    2023

    June 30,

    2024

    June 30,

    2023

    December 31,

    2023

    Sales

    1,752

    1,868

    3,487

    3,984

    7,536

    Cost of sales

    1,184

    1,189

    2,362

    2,459

    4,865

     

     

     

     

     

     

    Gross profit

    568

    679

    1,125

    1,525

    2,671

     

     

     

     

     

     

    Selling, transport and marketing expenses

    280

    279

    553

    543

    1,093

    General and administrative expenses

    64

    55

    128

    123

    260

    Research and development expenses

    14

    19

    31

    37

    71

    Other expenses

    2

    36

    5

    70

    128

    Other income

    (3)

    (10)

    (6)

    (13)

    (22)

     

     

     

     

     

     

    Operating income

    211

    300

    414

    765

    1,141

     

     

     

     

     

     

    Finance expenses

    59

    89

    119

    176

    259

    Finance income

    (26)

    (40)

    (51)

    (83)

    (91)

    Finance expenses, net

    33

    49

    68

    93

    168

     

     

     

     

     

     

    Share in earnings of equity-accounted investees

    -

    -

    -

    -

    1

     

     

     

     

     

     

    Income before taxes on income

    178

    251

    346

    672

    974

     

     

     

     

     

     

    Taxes on income

    48

    84

    90

    211

    287

     

     

     

     

     

     

    Net income

    130

    167

    256

    461

    687

     

     

     

     

     

     

    Net income attributable to the non-controlling interests

    15

    4

    32

    18

    40

     

     

     

     

     

     

    Net income attributable to the shareholders of the Company

    115

    163

    224

    443

    647

     

     

     

     

     

     

    Earnings per share attributable to the shareholders of the Company:

     

     

     

     

     

     

     

     

     

     

     

    Basic earnings per share (in dollars)

    0.09

    0.13

    0.17

    0.34

    0.50

     

     

     

     

     

     

    Diluted earnings per share (in dollars)

    0.09

    0.13

    0.17

    0.34

    0.50

     

     

     

     

     

     

    Weighted-average number of ordinary shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

    Basic (in thousands)

    1,289,901

    1,289,347

    1,289,716

    1,289,293

    1,289,361

     

     

     

     

     

     

    Diluted (in thousands)

    1,290,158

    1,290,792

    1,289,977

    1,290,950

    1,290,668

     

    Condensed Consolidated Statements of Financial Position as of (Unaudited)

    $ millions

    June 30,

    2024

    June 30,

    2023

    December 31,

    2023

    Current assets

     

     

     

    Cash and cash equivalents

    287

    372

    420

    Short-term investments and deposits

    109

    166

    172

    Trade receivables

    1,429

    1,380

    1,376

    Inventories

    1,544

    2,006

    1,703

    Prepaid expenses and other receivables

    298

    333

    363

    Total current assets

    3,667

    4,257

    4,034

     

     

     

     

    Non-current assets

     

     

     

    Deferred tax assets

    147

    149

    152

    Property, plant and equipment

    6,285

    6,097

    6,329

    Intangible assets

    857

    872

    873

    Other non-current assets

    249

    209

    239

    Total non-current assets

    7,538

    7,327

    7,593

     

     

     

     

    Total assets

    11,205

    11,584

    11,627

     

     

     

     

    Current liabilities

     

     

     

    Short-term debt

    577

    674

    858

    Trade payables

    834

    893

    912

    Provisions

    49

    75

    85

    Other payables

    802

    789

    783

    Total current liabilities

    2,262

    2,431

    2,638

     

     

     

     

    Non-current liabilities

     

     

     

    Long-term debt and debentures

    1,850

    2,117

    1,829

    Deferred tax liabilities

    500

    467

    489

    Long-term employee liabilities

    330

    362

    354

    Long-term provisions and accruals

    218

    236

    224

    Other

    61

    61

    56

    Total non-current liabilities

    2,959

    3,243

    2,952

     

     

     

     

    Total liabilities

    5,221

    5,674

    5,590

     

     

     

     

    Equity

     

     

     

    Total shareholders' equity

    5,746

    5,670

    5,768

    Non-controlling interests

    238

    240

    269

    Total equity

    5,984

    5,910

    6,037

     

     

     

     

    Total liabilities and equity

    11,205

    11,584

    11,627

     

    Condensed Consolidated Statements of Cash Flows (Unaudited)

    $ millions

    Three-months ended

    Six-months ended

    Year ended

    June 30,

    2024

    June 30,

    2023

    June 30,

    2024

    June 30,

    2023

    December 31,

    2023

    Cash flows from operating activities

     

     

     

     

     

    Net income

    130

    167

    256

    461

    687

    Adjustments for:

     

     

     

     

     

    Depreciation and amortization

    152

    141

    299

    271

    536

    Exchange rate, interest and derivative, net

    37

    30

    96

    48

    24

    Tax expenses

    48

    84

    90

    211

    287

    Change in provisions

    (11)

    (13)

    (53)

    (28)

    (32)

    Other

    2

    2

    4

    6

    29

     

    228

    244

    436

    508

    844

     

     

     

     

     

     

    Change in inventories

    58

    113

    109

    164

    465

    Change in trade receivables

    26

    268

    (115)

    233

    252

    Change in trade payables

    (55)

    (71)

    (29)

    (108)

    (101)

    Change in other receivables

    (14)

    1

    4

    (5)

    26

    Change in other payables

    (28)

    (184)

    (18)

    (207)

    (210)

    Net change in operating assets and liabilities

    (13)

    127

    (49)

    77

    432

     

     

     

     

     

     

    Income taxes paid, net of refund

    (29)

    (105)

    (35)

    (214)

    (253)

     

     

     

     

     

     

    Net cash provided by operating activities (*)

    316

    433

    608

    832

    1,710

     

     

     

     

     

     

    Cash flows from investing activities

     

     

     

     

     

    Proceeds (payments) from deposits, net

    11

    (35)

    61

    (79)

    (88)

    Purchases of property, plant and equipment and intangible assets

    (142)

    (170)

    (287)

    (334)

    (780)

    Interest received (*)

    3

    3

    10

    5

    10

    Proceeds from divestiture of assets and businesses, net of transaction expenses

    3

    -

    18

    3

    4

    Business combinations

    -

    -

    (22)

    -

    -

    Other

    -

    -

    -

    1

    1

    Net cash used in investing activities

    (125)

    (202)

    (220)

    (404)

    (853)

     

     

     

     

     

     

    Cash flows from financing activities

     

     

     

     

     

    Dividends paid to the Company's shareholders

    (59)

    (146)

    (120)

    (324)

    (474)

    Receipt of long-term debt

    140

    95

    338

    353

    633

    Repayments of long-term debt

    (226)

    (228)

    (612)

    (398)

    (836)

    Repayments of short-term debt

    (18)

    (54)

    (1)

    (17)

    (25)

    Interest paid (*)

    (43)

    (45)

    (63)

    (64)

    (125)

    Receipts from transactions in derivatives

    -

    -

    3

    6

    5

    Dividend paid to the non-controlling interests

    (57)

    (15)

    (57)

    (15)

    (15)

    Net cash used in financing activities

    (263)

    (393)

    (512)

    (459)

    (837)

     

     

     

     

     

     

    Net change in cash and cash equivalents

    (72)

    (162)

    (124)

    (31)

    20

    Cash and cash equivalents as of the beginning of the period

    363

    552

    420

    417

    417

    Net effect of currency translation on cash and cash equivalents

    (4)

    (18)

    (9)

    (14)

    (17)

    Cash and cash equivalents as of the end of the period

    287

    372

    287

    372

    420

     

    (*) Reclassified - see Note 2 to the Company's Interim Financial Statements.

    Adjustments to Reported Operating and Net Income (non-GAAP)

    $ millions

    Three-months ended

    Six-months ended

     

    June 30,

    2024

    June 30,

    2023

     

    June 30,

    2024

    June 30,

    2023

    Operating income

    211

    300

    414

    765

    Charges related to the security situation in Israel (1)

    14

    -

    26

    -

    Write-off of assets and provision for site closure (2)

    -

    -

    -

    15

    Total adjustments to operating income

    14

    -

    26

    15

    Adjusted operating income

    225

    300

    440

    780

    Net income attributable to the shareholders of the Company

    115

    163

    224

    443

    Total adjustments to operating income

    14

    -

    26

    15

    Total tax adjustments (3)

    (3)

    -

    (6)

    (3)

    Total adjusted net income - shareholders of the Company

    126

    163

    244

    455

     

    (1)

    For 2024, reflects charges relating to the security situation in Israel.

    (2)

    For 2023, reflects mainly a write-off of assets related to restructuring at certain sites, including site closures and facility modifications, as part of the Company's global efficiency plan.

    (3)

    For 2024 and 2023, reflects the tax impact of adjustments made to operating income.

    Consolidated EBITDA for the Periods of Activity

    $ millions

    Three-months ended

    Six-months ended

     

    June 30,

    2024

    June 30,

    2023

    June 30,

    2024

    June 30,

    2023

    Net income

    130

    167

    256

    461

    Financing expenses, net

    33

    49

    68

    93

    Taxes on income

    48

    84

    90

    211

    Operating income

    211

    300

    414

    765

    Depreciation and amortization

    152

    141

    299

    271

    Adjustments (1)

    14

    -

    26

    15

    Total adjusted EBITDA (2)

    377

    441

    739

    1,051

     

    (1)

    See "Adjustments to Reported Operating and Net income (non-GAAP)" above.

    (2)

    In the first half of 2024, the Company's adjusted EBITDA was positively impacted by an immaterial accounting reclassification. For further information, see below in our Potash segment results.

    Calculation of Segment EBITDA

    $ millions

    Industrial Products

    Potash

    Phosphate Solutions (1)

    Growing Solutions

     

    Three-months ended

     

    June 30,

    2024

    June 30,

    2023

    June 30,

    2024

    June 30,

    2023

    June 30,

    2024 (2)

    June 30,

    2023

    June 30,

    2024

    June 30,

    2023

    Segment operating income

    60

    60

    60

    167

    93

    73

    25

    4

    Depreciation and amortization

    14

    14

    58

    46

    53

    56

    20

    18

    Segment EBITDA

    74

    74

    118

    213

    146

    129

    45

    22

     

    (1)

    In alignment with the Company's efficiency plan, which includes a change of reporting responsibilities as of January 2024, the results of a non-phosphate related business were allocated from the Phosphate Solutions segment to Other Activities. Comparative figures have been restated to reflect the organizational change in the reportable segments.

    (2)

    For Q2 2024, Phosphate Specialties comprised $325 million of segment sales, $46 million of operating income, $11 million of D&A and represented $57 million of EBITDA, while Phosphate Commodities comprised $247 million of segment sales, $47 million of operating income, $42 million of D&A and represented $89 million of EBITDA.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240813642054/en/

    Get the next $ICL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ICL

    DatePrice TargetRatingAnalyst
    1/21/2025$4.00 → $6.00Underweight → Equal Weight
    Barclays
    1/12/2024$6.50 → $4.00Overweight → Underweight
    Barclays
    11/14/2023$7.00 → $6.50Equal Weight → Overweight
    Barclays
    5/18/2023Buy → Neutral
    BofA Securities
    6/1/2022$12.00Equal Weight
    Barclays
    2/14/2022$9.00 → $10.00Equal-Weight
    Morgan Stanley
    12/6/2021$7.00 → $9.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ICL
    SEC Filings

    See more
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/20/25 4:20:09 PM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/19/25 2:51:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form 6-K filed by ICL Group Ltd.

      6-K - ICL Group Ltd. (0000941221) (Filer)

      5/19/25 6:50:24 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ICL Group upgraded by Barclays with a new price target

      Barclays upgraded ICL Group from Underweight to Equal Weight and set a new price target of $6.00 from $4.00 previously

      1/21/25 7:50:33 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Group downgraded by Barclays with a new price target

      Barclays downgraded ICL Group from Overweight to Underweight and set a new price target of $4.00 from $6.50 previously

      1/12/24 6:56:19 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Group upgraded by Barclays with a new price target

      Barclays upgraded ICL Group from Equal Weight to Overweight and set a new price target of $6.50 from $7.00 previously

      11/14/23 7:37:49 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ICL Reports First Quarter 2025 Results

      Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net in

      5/19/25 1:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces First Quarter 2025 Earnings Call

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (646) 564-2877 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employees,

      4/23/25 8:00:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • Israel Corp. Reports Results for Fourth Quarter of 2024

      TEL AVIV, Israel, March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024. Selected Financial Figures for the Fourth Quarter 2024: $m Q3/24 Q3/23 2024 2023 ILCO share in ICL profit1 30 28 175 282 Financing, G&A and other at ILCO headquarter level  2 1 - (8) Tax income (expense) of ILCO Headquarters (1) (1) 15 (1) Net profit to company's shareholders 31 28 190 273 Liquidity at the ILCO Headquarters Level2 As of December 31, 2024, total financial liabilities were $733 million, and investments in liquid assets amounted to $882 million of which $83 million are pledged deposits. Net

      3/27/25 5:48:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by ICL Group Ltd.

      SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

      11/14/24 6:11:02 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G filed by ICL Group Ltd.

      SC 13G - ICL Group Ltd. (0000941221) (Subject)

      1/31/24 6:05:59 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • SEC Form SC 13G/A filed by ICL Group Ltd. (Amendment)

      SC 13G/A - ICL Group Ltd. (0000941221) (Subject)

      1/30/24 8:10:40 AM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Leadership Updates

    Live Leadership Updates

    See more
    • ICL Announces Appointment of Elad Aharonson as New President and Chief Executive Officer

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced its Board of Directors has approved the appointment of Elad Aharonson as ICL's new president and chief executive officer, effective March 13, 2025. He will succeed Raviv Zoller who will work with Aharonson to ensure a smooth and orderly transition. Elad Aharonson has been an integral part of ICL for nearly four years, serving as president of ICL's Growing Solutions business since April of 2021. During his tenure, he led the development of ICL's specialty fertilizer solutions and the expansion of these product offerings into new territories, through both organic efforts and via acquisitions. His signif

      12/23/24 2:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces Planned Departure of President and CEO Raviv Zoller

      Zoller to continue to serve the company until a replacement has been announced ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Raviv Zoller, the company's president and CEO for the past seven years, is expected to leave the company in early 2025, following both the appointment of a replacement and a formal transition. In a letter to the company's employees, Zoller wrote, "I feel great pride, mixed with sorrow, as I announce my expected retirement from the position as president and CEO of ICL. Over the past seven years at this amazing organization, I have come to know our employees who give their heart and soul to the company. Together, we ha

      12/5/24 7:21:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Recognized by Fortune as a Company That is Changing the World

      Company's Agmatix AI-driven data platform and RegenIQ framework designated as a Friend of Farmers ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced that Agmatix, the company's ag tech digital start-up, has been named to Fortune's 10th Annual Change the World list. The list recognizes companies that have had a positive social impact through activities that are part of their core business strategy. Among other factors, nominees are assessed on their measurable impact on people and the planet, profitability related to their impactful work, and the degree of innovation they have demonstrated. Agmatix was recognized for its AI-driven platform, which helps

      10/15/24 4:15:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials

    $ICL
    Financials

    Live finance-specific insights

    See more
    • ICL Reports First Quarter 2025 Results

      Sales of $1.8 billion increased year-over-year, with operating income of $185 million, adjusted EBITDA of $359 million and adjusted diluted EPS of $0.09 ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributable to shareholders was $91 million versus $109 million in the prior year, with adjusted net in

      5/19/25 1:10:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • ICL Announces First Quarter 2025 Earnings Call

      ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The dial-in number for financial analysts in North America is (800) 549-8228, or (646) 564-2877 for international analysts, and the conference ID is ICL. To participate, please dial in a few minutes before the scheduled time. Employees,

      4/23/25 8:00:00 AM ET
      $ICL
      Agricultural Chemicals
      Industrials
    • Israel Corp. Reports Results for Fourth Quarter of 2024

      TEL AVIV, Israel, March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024. Selected Financial Figures for the Fourth Quarter 2024: $m Q3/24 Q3/23 2024 2023 ILCO share in ICL profit1 30 28 175 282 Financing, G&A and other at ILCO headquarter level  2 1 - (8) Tax income (expense) of ILCO Headquarters (1) (1) 15 (1) Net profit to company's shareholders 31 28 190 273 Liquidity at the ILCO Headquarters Level2 As of December 31, 2024, total financial liabilities were $733 million, and investments in liquid assets amounted to $882 million of which $83 million are pledged deposits. Net

      3/27/25 5:48:00 PM ET
      $ICL
      Agricultural Chemicals
      Industrials